共 102 条
[1]
Cross M(2014)The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study Ann Rheum Dis 73 1316-1322
[2]
Smith E(2003)Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years Ann Rheum Dis 62 722-727
[3]
Hoy D(2010)The impact of rheumatoid arthritis and treatment on patients' lives Clin Exp Rheumatol 28 S32-S40
[4]
Carmona L(2015)Cardiovascular comorbidity in rheumatic diseases Nature Reviews Rheumatology 11 693-704
[5]
Wolfe F(2017)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis 76 960-977
[6]
Vos T(2006)First Latin American position paper on the pharmacological treatment of rheumatoid arthritis Rheumatology (Oxford) 45 ii7-ii22
[7]
Turesson C(2011)Advances in the medical treatment of rheumatoid arthritis Hand Clin 27 11-20
[8]
O'Fallon WM(2011)Use of biologics in rheumatoid arthritis: current and emerging paradigms of care Clin Ther 33 679-707
[9]
Crowson CS(2009)Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy Patient Prefer Adherence 3 335-344
[10]
Gabriel SE(2009)Treatment of rheumatoid arthritis: we are getting there Lancet 374 178-180